ArticleFrontiers in endocrinology2022

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report.

Angela Dardano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.